A Prospective Multicenter Registry Study on BASIS Technique for Endovascular Therapy of Acute Large Vessel Occlusion Strokes Due to Intracranial Atherosclerotic Disease
1 other identifier
observational
250
1 country
1
Brief Summary
This study will explore the safety and efficacy of BASIS technology in ICAS-LVO lesions through a multicenter, prospective, registry, observational single-arm study.By registering intraoperative recanalization using this technique time, recanalization grade, operative thrombectomy times, intraoperative complications perforating branch occlusion, vascular dissection, vascular rupture, Ectopic thrombus, probability of symptomatic intracranial hemorrhage, mRS Score and mortality rate were followed up for 3 months The unique advantages of the application of the assessment BASIS in this type of lesion provide new insights into complex lesions such as ICAS-LVO The thought and operation method can shorten the operation time, improve the good prognosis, reduce the economic burden and reduce the operation Complications make a positive contribution to ensure that patients receive safe, effective and precise treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
January 19, 2025
CompletedFirst Posted
Study publicly available on registry
March 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 18, 2025
January 1, 2025
2 years
January 19, 2025
March 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
mRS scores at 90 days
functional recovery, assessed by change in modified Rankin Scale (mRS) scores (ranging from 0 \[no symptoms\] to 6 \[death\]) at 90 days after onset
90 days
FPE:first pass effect
Vascular revascularization rate by basis technique at the first attempt
From enrollment to the end of the surgery about 3 hours
Secondary Outcomes (1)
Residual stenosis rate of target vessel
From enrollment to the end of the surgery about 3 hours
Study Arms (1)
using BASIS technique
Interventions
Balloon AngioplaSty with the dIstal protection of Stent retriever
Eligibility Criteria
ICAS-LAO stroke
You may qualify if:
- Age ≥18 years old;
- Ischemic stroke;
- Within 72 hours from the onset of symptoms to the time of visit, including post-awakening stroke or blindness For stroke patients, the time when symptoms start is defined as "the last normal time";
- Neuroimaging examination indicated occlusion of anterior or posterior intracranial large vessels, TOAST type was large atherosclerosis type.
- BASIS technique was used for intravascular therapy.
You may not qualify if:
- Neuroimaging findings on admission, acute occlusion of multiple vessels and tandem lesions;
- History of atrial fibrillation or heart valve surgery;
- There are clinical contraindications to the use of antiplatelet drugs (hemophilia or thrombocytopenia).Rare disease, known history of coagulation disorders, platelet abnormalities; There is active internal bleeding, intracranial Bleeding history, arteriovenous malformation, aneurysm, etc.);
- Other types of stroke, including hemorrhagic stroke.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 19, 2025
First Posted
March 18, 2025
Study Start
January 1, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
March 18, 2025
Record last verified: 2025-01